Technology Strategy Board appoints Cell Therapy Catapult CEO

Technology Strategy Board appoints Cell Therapy Catapult CEO

27 Apr 2012

The Technology Strategy Board has appointed life science innovator Keith Thompson as Chief Executive Office (CEO) of the Catapult centre in cell therapy.

Mr Thompson brings strong leadership and considerable senior executive and management experience in the biotechnology industry both in the UK and abroad.

Mr Thompson will be responsible for short and long term objectives of the Catapult, including where the centre will be based and recruiting an executive team. He will also be in charge of developing and delivering against a robust business plan and key milestones that will help grow the industry.

When operational, the cell therapy Catapult will work to grow a viable and sustainable UK based cell therapy industry with access to finance, clinical and technical expertise to allow the rapid exploitation of cell therapies. The Catapult will enable the UK to be a global leader in the development and commercial exploitation of cell therapies and encourage inward investment to support the growth of the commercial sector. It will also work with UK companies to help turn innovations in cell therapies into commercial products capable of transforming the lives of people with serious or chronic illnesses.

Mr Thompson joins the Catapult from the Scottish National Blood Transfusion Service (SNBTS). As Director of the SNBTS he was responsible for all aspects of the service including the safe and sufficient supply of blood and tissues, as well as diversifying its capability to offer cell based therapies. Prior to this Thompson held various senior domestic and international positions where he grew several small bio-manufacturing businesses to become global players.

The Catapult is part of a network of world-leading technology and innovation centres established and overseen by the Technology Strategy Board as a long-term investment that will open up global opportunities for the UK and generate economic growth for the future.

The cell therapy Catapult will be based in London and aims to open for business in the autumn.

View the press release here

Visit the catapult website here

This video requires flash version 7 or higher to play.

Last updated on Friday 27 April 2012 at 14:07

More like this

Copyright © 2013